Investor Update

Basel, 25 February 2015

Launch of the Anti-Cancer Agent / BRAF Inhibitor "Zelboraf"

Contribution to the Treatment of Melanoma by Personalized Healthcare

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.